Authors:
Moreland, LW
Cohen, SB
Baumgartner, SW
Tindall, EA
Bulpitt, K
Martin, R
Weinblatt, M
Taborn, J
Weaver, A
Burge, DJ
Schiff, MH
Citation: Lw. Moreland et al., Longterm safety and efficacy of etanercept in patients with rheumatoid arthritis, J RHEUMATOL, 28(6), 2001, pp. 1238-1244
Authors:
Yocum, DE
Allard, S
Cohen, SB
Emery, P
Flipo, RM
Goobar, J
Jayawardena, S
Job-Deslandre, C
Jubb, RW
Kruger, K
Vaz, AL
Manger, B
Mur, E
Nygaard, H
Weiner, SM
Rainer, F
Sack, MR
Schiff, MH
Schnitzer, TJ
Trigg, LB
Whatmough, I
Schmidt, AG
Citation: De. Yocum et al., Microemulsion formulation of cyclosporin (Sandimmun Neoral (R)) vs Sandimmun (R): Comparative safety, tolerability and efficacy in severe active rheumatoid arthritis, RHEUMATOLOG, 39(2), 2000, pp. 156-164
Citation: Mh. Schiff et A. Whelton, Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis, SEM ARTH RH, 30(3), 2000, pp. 196-208
Authors:
Bathon, JM
Martin, RW
Fleischmann, RM
Tesser, JR
Schiff, MH
Keystone, EC
Genovese, MC
Wasko, MC
Moreland, LW
Weaver, AL
Markenson, J
Finck, BK
Citation: Jm. Bathon et al., A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis, N ENG J MED, 343(22), 2000, pp. 1586-1593
Authors:
Schiff, MH
Strand, V
Oed, C
Loew-Friedrich, I
Citation: Mh. Schiff et al., Leflunomide: Efficacy and safety in clinical trials for the treatment of rheumatoid arthritis, DRUGS TODAY, 36(6), 2000, pp. 383-394
Citation: Mh. Schiff, Role of interleukin 1 and interleukin 1 receptor antagonist in the mediation of rheumatoid arthritis, ANN RHEUM D, 59, 2000, pp. 103-108
Authors:
Moreland, LW
Schiff, MH
Baumgartner, SW
Tindall, EA
Fleischmann, RM
Bulpitt, KJ
Weaver, AL
Keystone, EC
Furst, DE
Mease, PJ
Ruderman, EM
Horwitz, DA
Arkfeld, DG
Garrison, L
Burge, DJ
Blosch, CM
Lange, MLM
McDonnell, ND
Weinblatt, ME
Citation: Lw. Moreland et al., Etanercept therapy in rheumatoid arthritis - A randomized, controlled trial, ANN INT MED, 130(6), 1999, pp. 478